2023 annual financial data
Telomir Pharmaceuticals 2023 Operating margin
Telomir Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -3,942,048 USD and net income was -13,071,864 USD.
Operating cash flow was -3,859,796 USD.
Get free Telomir Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -3,942,048 USD
- Net income
- -13,071,864 USD
- Operating cash flow
- -3,859,796 USD